Moore Capital Management’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $5.62M | Buy |
|
|||||
|
2025
Q2 | $2.82M | Buy |
|
|||||
|
2025
Q1 | $1.85M | Hold |
|
|||||
|
2024
Q4 | $2.16M | Hold |
|
|||||
|
2024
Q3 | $2.17M | Hold |
|
|||||
|
2024
Q2 | $2.14M | Hold |
|
|||||
|
2024
Q1 | $2.37M | Sell |
|
|||||
|
2023
Q4 | $2.99M | Buy |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $1.23M | Sell |
|
|||||
|
2022
Q4 | $5.1M | Buy |
|
|||||
|
2022
Q3 | $3.72M | Sell |
|
|||||
|
2022
Q2 | $5.23M | Buy |
|
|||||
|
2022
Q1 | $877K | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $656K | Hold |
|
|||||
|
2019
Q3 | $451K | Hold |
|
|||||
|
2019
Q2 | $493K | Hold |
|
|||||
|
2019
Q1 | $508K | Hold |
|
|||||
|
2018
Q4 | $316K | Buy |
|
|||||
|
2018
Q3 | $198K | Buy |
|